Gain Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GANX and other ETFs, options, and stocks.

About GANX

Gain Therapeutics, Inc. is a redefining drug discovery company, which identifies and optimizes allosteric binding sites that never targeted before. Its See-Tx target identification platform uses the published 3D structure of enzymes and a proprietary computational technology to discover new allosteric binding sites and predict their druggability. 

CEO
Gene C. Mack
CEOGene C. Mack
Employees
25
Employees25
Headquarters
Bethesda, Maryland
HeadquartersBethesda, Maryland
Founded
2017
Founded2017
Employees
25
Employees25

GANX Key Statistics

Market cap
76.73M
Market cap76.73M
Price-Earnings ratio
-4.10
Price-Earnings ratio-4.10
Dividend yield
Dividend yield
Average volume
840.36K
Average volume840.36K
High today
$2.75
High today$2.75
Low today
$1.93
Low today$1.93
Open price
$2.50
Open price$2.50
Volume
2.15M
Volume2.15M
52 Week high
$4.34
52 Week high$4.34
52 Week low
$1.41
52 Week low$1.41

Stock Snapshot

The current Gain Therapeutics(GANX) stock price is $2.00, with a market capitalization of 76.73M. The stock trades at a price-to-earnings (P/E) ratio of -4.10.

During the trading session on 2026-03-18, Gain Therapeutics(GANX) shares reached a daily high of $2.75 and a low of $1.93. At a current price of $2.00, the stock is +3.4% higher than the low and still -27.5% under the high.

Trading activity shows a volume of 2.15M, compared to an average daily volume of 840.36K.

The stock's 52-week range extends from a low of $1.41 to a high of $4.34.

The stock's 52-week range extends from a low of $1.41 to a high of $4.34.

People also own

Based on the portfolios of people who own GANX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.